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Standards of practice are dictated by measures of suc-
cess, and success, in turn, is determined by the objectives of
intervention. In the case of an aortic aneurysm, we inter-
vene to prevent rupture and death, and so, by definition,
primary outcome criteria for endovascular aneurysm repair
include the prevention of aneurysm rupture, death from
aneurysm rupture, and aneurysm-related death that may
result from primary or secondary treatment. Nonetheless,
there is now ample evidence that the mere presence of an
endograft does not necessarily prohibit aneurysm rupture
and death. Thus, surrogate markers that suggest a continu-
ing or increasing risk of rupture, such as aneurysm enlarge-
ment or endoleak, clearly play a critical role in the overall
assessment of the success of endovascular treatment strate-
gies. Moreover, there is little doubt that other outcome
variables, such as the incidence and severity of periproce-
dural morbidity, device integrity, quality of life, need for
secondary interventions, and cost-effectiveness significantly
impact our interpretation of overall clinical efficacy. These
and other issues have recently been considered by the
Society for Vascular Surgery/American Association for
Vascular Surgery Ad Hoc Committee on Reporting Stan-
dards for Aortic Aneurysm Repair, and detailed recommen-
dations regarding outcome analysis have been reported.1
In this issue of the Journal, Arko and colleagues2 at
Stanford University present a detailed outcome analysis of
patients with abdominal aortic aneurysm treated either by
open or endovascular repair. This is an important effort, for
it provides additional perspective regarding our capacity to
safely and reliably treat patients by using the AneuRx device
at a center of excellence. Moreover, as increasing numbers
of investigations seek to carefully compare both open and
endovascular strategies, all of us in the vascular surgical
community will benefit from a more precise definition of
what we presume to be the advantages or limitations of
each these two distinct approaches. For example, there
currently exists little disagreement regarding the ability of
an endovascular approach to reduce hospital stay, intensive
care unit utilization, major morbidity and to improve qual-
ity of life in the perioperative period. It is possible, however,
that these benefits may be offset by higher initial costs,
increased expenditures related to monitoring and reinter-
vention, as well as psychological stress associated with the
potential for aneurysm recurrence. Precise measurements
of these variables have been and will continue to be valu-
able.
In strict terms, rigorous comparison of two distinct
study populations requires prospective randomization be-
cause this process provides a mechanism for equal distribu-
tion among treatment arms of all factors, both recognized
and hidden, that might modify outcome. Unfortunately,
practical considerations often limit the use of randomiza-
tion and although an acceptable substitute for randomiza-
tion does not exist, adjusting for case severity mix, however
imprecise, does provide a mechanism to obtain some mea-
sure of confidence in comparing the outcomes of two or
more treatment protocols. In general, it would be inappro-
priate to compare the outcomes of endograft repair be-
tween two distinct interventions, if one was populated with
healthy patients and relatively small aneurysms, whereas the
other treated more complex aneurysms among patients
with significant comorbidities. Indeed, the Stanford group
has attempted to account for the presence of associated
medical comorbidities among their patients. However, fu-
ture efforts directed at comparing open surgery and endo-
vascular treatment may be better assisted by the use of
severity scoring schemes, recently proposed by the Ad Hoc
Committee on Reporting Standards, that endeavor to es-
tablish a more quantitative mechanism for assessing comor-
bid medical conditions and relevant anatomic factors.3 For
example, there exists some debate as to whether endovas-
cular grafting provides an unequivocal reduction in periop-
erative mortality as compared with open repair in the
otherwise healthy adult. Such schemes may help to confirm
the benefit observed in this report and increase our confi-
dence in the potential advantages of this new technology.
Although success is comprised of a variety of factors,
aneurysm-related death, as noted in the Stanford report, is
clearly an important determinant of clinical effectiveness. It
is significant that the authors emphasize that late graft- or
treatment-related complications and death may occur after
both open and endovascular repair and a careful accounting
is required in any comparison of these two treatments.
Although many factors need to be included in deciding
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upon the best option for aneurysm management, reliable
data regarding the anticipated risk of aneurysm-related
death will certainly be an important element of any discus-
sion with a prospective patient. While the Stanford group
proposes the use of an aneurysm-related death rate, defined
as the total number of aneurysm related-deaths during a
study period, a much more appropriate method for present-
ing the risk of aneurysm-related death is by Kaplan-Meier
analysis. Indeed, the statistical analysis of aneurysm-related
death rates, as proposed by Arko and colleagues, is not
particularly precise or meaningful. Specifically, a death rate
is a time-dependent variable and any comparative analysis
mandates that statistical testing be performed at a valid
time-point. In this regard, comparing the overall incidence
of aneurysm-related deaths in an attempt to estimate a
death rate is misleading when one considers that the mean
follow-up periods for patients undergoing open and endo-
vascular repair were respectively, 16.6  12.8 months and
11.8 9.5 months. The broad standard deviations for each
of the study groups precludes a precise determination of the
relevant period for comparison, nor does it allow any esti-
mate to be placed on the upper or lower bounds of the
proposed death rate. The rationale for the preferred use of
Kaplan-Meier curves in the analysis of patency after angio-
plasty or bypass grafting is similar, since other proposed
“statistical” approaches may lose important insight into
accurate changes in event probability over time. However,
it should be emphasized that Kaplan-Meier probabilities
can also be misused and, at a given time-point calculated
risks are most valid if the associated standard error is10%.
In this report, the data are what they are and a statistically
significant difference was not observed by Kaplan-Meier
analysis in the risk of aneurysm-related deaths between
patients undergoing either open or endovascular repair.
Given the other advantages of endovascular treatment, this
observation should be considered encouraging, albeit at a
relatively early time-point after graft implantation.
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